/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, capped off a successful 2022 with continued growth, maturity, and.
/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, today announced the release of an integrated, plug-and-play software.
/PRNewswire/ Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a.
/PRNewswire/ Curebase, a company dedicated to democratizing clinical trials through a decentralized model, today announced a partnership with BEKHealth, a.